2)
Imatinib treatment inhibits IL-6, IL-8, NF-KB and
AP-1 production and modulate intracellular calcium in CML patients.
Ciarcia R, Vitiello MT, Galdiero M, Pacilio C,
Iovane V, d'Angelo D, Pagnini D, Caparrotti G, Conti D, Tomei V, Florio
S, Giordano A.
J Cell Physiol.
2011 Sep 21. |